Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Marco Pirisinu: Highlights Potential of PDEVs in Drug Delivery
Marco Pirisinu/LinkedIn
Aug 12, 2025, 01:27

Marco Pirisinu: Highlights Potential of PDEVs in Drug Delivery

Marco Pirisinu, Director of Business Development at Jotbody, shared a post on LinkedIn:

“Hey everyone,

I recently came across a review discussing the potential of plant-derived extracellular vesicles (PDEVs) in drug delivery.

Some highlights:

• Natural Carriers: PDEVs naturally encapsulate bioactive molecules like proteins, lipids, and RNAs, which can synergize with therapeutic agents.
• Biocompatibility: Being plant-based, they exhibit low immunogenicity, reducing potential adverse reactions.
• Stability: PDEVs demonstrate resilience under various conditions, ensuring the integrity of encapsulated drugs.
• Scalability: Plants offer a sustainable and scalable source for vesicle production, facilitating large-scale applications.

These attributes make PDEVs a promising avenue for delivering a range of therapeutic agents, including small molecules, proteins, and nucleic acids.

I will also put the reference here“.

Marco Pirisinu: Highlights Potential of PDEVs in Drug Delivery

All the latest news in the World of Hematology featured in Hemostasis Today.

bioactive molecules Biocompatibility Health Hematology Hemostasis Today immunogenicity Medicine PDEVs Scalability Stability
NewsFeed